Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 8, 2010, Pages 1013-1019

  Jan Willem Borleffs, C ^a   Thijssen, Joep ^a   De Bie, Mihály K ^a   Van Rees, Johannes B ^a   Van Welsenes, Guido H ^a   Van Erven, Lieselot ^a   Bax, Jeroen J ^a   Cannegieter, Suzanne C ^a   Schalij, Martin J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

complications; implantable cardioverter defibrillator; infection; replacement; sudden death

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE INFECTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RECURRENCE RISK; REOPERATION; SUDDEN DEATH; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT INDICATION;

DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; EQUIPMENT FAILURE; FEMALE; FOREIGN-BODY MIGRATION; HEMATOMA; HUMANS; INFECTION; MALE; MIDDLE AGED; PRESSURE ULCER; REOPERATION;

EID: 77955320887     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02780.x     Document Type: Article

References (28)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997 337 : 1576 1583.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
3. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999 341 : 1882 1890.
4. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000 101 : 1297 1302.
5. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000 102 : 748 754.
6. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996 335 : 1933 1940.
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
8. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, III., Freedman RA, Gettes LS, Gillinov AM, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008 117 : e350-e408.
9. Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman DB, Schultz DB. Pacemaker and ICD generator malfunctions: Analysis of Food and Drug Administration annual reports. JAMA 2006 295 : 1901 1906.
10. Biffi M, Ziacchi M, Bertini M, Sangiorgi D, Corsini D, Martignani C, Diemberger I, et al. Longevity of implantable cardioverter-defibrillators: Implications for clinical practice and health care systems. Europace 2008 10 : 1288 1295.
11. Hauser RG. The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J Am Coll Cardiol 2005 45 : 2022 2025.
12. Borleffs CJ, Wilde AA, Cramer MJ, Wever E, Mosterd A. Clinical implementation of guidelines for cardioverter defibrillator implantation: Lost in translation? Neth Heart J 2007 15 : 129 132.
13. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007 116 : 1349 1355.
14. Lekkerkerker JC, van NC, Trines SA, Van Der Bom JG, Bernards A, van d, V, Bootsma M, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009 95 : 715 720.
15. Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 2006 295 : 1907 1911.
16. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114 : e385 e484.
17. Borleffs CJ, van EL, Schotman M, Boersma E, Kies P, Van Der Burg AE, Zeppenfeld K, et al. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: Long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT). Eur Heart J 2009 30 : 1621 1626.
18. Van Der Burg AE, Bax JJ, Boersma E, van EL, Bootsma M, Van Der Wall EE, Schalij MJ. Standardized screening and treatment of patients with life-threatening arrhythmias: The Leiden out-of-hospital cardiac arrest evaluation study. Heart Rhythm 2004 1 : 51 57.
19. Borleffs CJ, van Erven L, van Bommel RJ, Van Der Velde ET, Van Der Wall EE, Bax JJ, Rosendaal FR, et al. Risk of failure of transvenous implantable cardioverter defibrillator leads. Circ Arrhythmia Electrophysiol 2009 2 : 411 416.
20. Sohail MR. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. 2007.
21. Hauser RG, Almquist AK. Learning from our mistakes? Testing new ICD technology. N Engl J Med 2008 359 : 2517 2519.
22. Costea A, Rardon DP, Padanilam BJ, Fogel RI, Prystowsky EN. Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol 2008 19 : 266 269.
23. Harcombe AA, Newell SA, Ludman PF, Wistow TE, Sharples LD, Schofield PM, Stone DL, et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart 1998 80 : 240 244.
24. Kapa S, Hyberger L, Rea RF, Hayes DL. Complication risk with pulse generator change: Implications when reacting to a device advisory or recall. Pacing Clin Electrophysiol 2007 30 : 730 733.
25. Leon AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J, Hayes DL, et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: Combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 2005 46 : 2348 2356.
26. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, Fowler VG Jr. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004 147 : 582 586.
27. Da CA, Lelievre H, Kirkorian G, Celard M, Chevalier P, Vandenesch F, Etienne J, et al. Role of the preaxillary flora in pacemaker infections: A prospective study. Circulation 1998 97 : 1791 1795.
28. Wade JS, Cobbs CG. Infections in cardiac pacemakers. Curr Clin Top Infect Dis 1988 9 : 44 61.